Outcomes for Congenital Diaphragmatic Hernia in Three Decades: A Report From a UK Surgical Centre
Issued Date
2025-01-01
Resource Type
ISSN
08035253
eISSN
16512227
Scopus ID
2-s2.0-105015174548
Pubmed ID
40892312
Journal Title
Acta Paediatrica International Journal of Paediatrics
Rights Holder(s)
SCOPUS
Bibliographic Citation
Acta Paediatrica International Journal of Paediatrics (2025)
Suggested Citation
Lee W.T., Losty P.D. Outcomes for Congenital Diaphragmatic Hernia in Three Decades: A Report From a UK Surgical Centre. Acta Paediatrica International Journal of Paediatrics (2025). doi:10.1111/apa.70295 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112060
Title
Outcomes for Congenital Diaphragmatic Hernia in Three Decades: A Report From a UK Surgical Centre
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Aims: Congenital diaphragmatic hernia (CDH) is associated with lung hypoplasia, pulmonary hypertension and high mortality. Three decades experience from a UK centre is reported. Methods: Medical records of CDH newborns between February 1990 and November 2021 and attending a multidisciplinary clinic were examined. Survival and health outcomes are recorded. Results: Of 220 CDH newborns, left-sided defects were 177 (80%) cases. Diaphragm patch was required in 91 (41%) patients and 42 (19%) additionally required abdominal wall prosthesis. Materials deployed included Gore-Tex biological Surgisis patches all had early recurrences. Diaphragmatic patch was significantly associated with fundoplication (p 0.005). Overall survival rate was 85%—(90% survival primary defect vs. 79% patch) (p 0.035). Comparing decades, the post-2010 CDH study cohort was a sicker patient group comprising more index cases with cardiac malformations (69% vs. 28%, p < 0.001) requiring greater cardiovascular inotrope support (61% vs. 25%, p < 0.001) and ECMO (15% vs. 5%, p 0.023). Conclusion: While a modestly excellent 85% survival rate is reported over three decades, CDH management at this UK university surgical centre witnessed a growing complexity of patients with mixed severity phenotype(s). Future challenges remain to be solved to improve survival for the most complex vulnerable patients.